Latest news with #Anti-DopingRules
The Hindu
30-07-2025
- Sport
- The Hindu
EXPLAINED: World Athletics' SRY gene test for athletes wishing to compete in the female category
The World Athletics Council has approved new regulations concerning eligibility conditions to compete in the female category for world ranking competitions. The new regulations will come into effect on September 1, 2025 and will be applied to the World Athletics Championships in Tokyo, that begins on September 13. All athletes wishing to compete in the female category at the World Championships are required to undergo a once-in-a-lifetime test for the SRY gene – a reliable proxy for determining biological sex. This is to be conducted via a cheek swab or blood test, whichever is more convenient. The testing protocol will be overseen by individual athletics federations as they prepare their athletes and teams for Tokyo Championships. World Athletics President Sebastian Coe labelled this move an important step in attracting more women to athletics. 'The philosophy that we hold dear in World Athletics is the protection and the promotion of the integrity of women's sport. It is really important in a sport that is permanently trying to attract more women that they enter a sport believing there is no biological glass ceiling. The test to confirm biological sex is a very important step in ensuring this is the case. 'We are saying, at elite level, for you to compete in the female category, you have to be biologically female. It was always very clear to me and the World Athletics Council that gender cannot trump biology,' added Coe. The new regulations follow recommendations from the Gender Diverse Athlete Working Group approved by Council in March 2025. The female athlete category is defined in WA's Eligibility Rule 3.5, which states that only the following athletes may compete in this category: a. Biological females. b. Biological females who have used testosterone as part of male gender-affirming treatment further to a Therapeutic Use Exemption granted in accordance with World Athletics' Anti-Doping Rules may not compete in the female category until the passing of a period of time after their last use of testosterone (the period of time will be not shorter than four years and will be determined by World Athletics on a case-by-case basis taking into consideration all relevant factors including the timing, duration, dosages and effects of the male gender-affirming treatment). c. Biological males who have Complete Androgen Insensitivity Syndrome and therefore have not gone through male sexual development including any type of male puberty. d. Biological males with a difference of sex development who satisfy the transitional provisions issued by World Athletics.
Yahoo
19-03-2025
- Sport
- Yahoo
Ex-Warrington Wolves youngster banned after positive test for banned substance
A FORMER Warrington Wolves youngster has been handed a lengthy ban after testing positive for a banned substance. As part of the terms of his suspension, however, winger Josh Lynch will be able to return to playing rugby league this summer after it was deemed he had not acted intentionally. Lynch came through the Wire academy to make his senior debut against Huddersfield Giants in August 2022, scoring a try in a 38-36 defeat. That proved to be his only senior appearance for Warrington as he spent the 2023 campaign on loan at North Wales Crusaders, scoring six tries in 18 matches. However, having been tested by UK Anti-Doping after a pre-season training session with The Wire during December 2023, his sample returned an adverse analytical finding for ibutamoren – a growth hormone that is prohibited in sport. After a charge was issued and mitigation on Lynch's behalf was considered, the Welsh outside-back has been handed a 16-month ban from all sporting activity backdated from February 2, 2024 – the date upon which Lynch received his charge notice and was provisionally suspended. As such, he will be eligible to compete again from June 2 of this year. In a statement released by UKAD, they say it was determined Lynch's explanation that he ingested ibutamoren accidentally having made a protein shake with a contaminated blender that had been used by a friend to make a shake containing the banned substance was plausible. As a result, they were able to conclude that he did not act with intent. 'UKAD instructed an independent scientific expert to provide an opinion on the pharmacokinetic plausibility of Mr Lynch's account,' the UKAD statement read. 'The expert concluded that Mr Lynch's explanation was plausible and, later, further indicated that, had Mr Lynch been a regular user of ibutamoren, he would have expected such use to be apparent by way of an AAF in the Sample provided by Mr Lynch on 22 January. 'UKAD referred the matter to the independent National Anti-Doping Panel (NADP) and a Panel was convened to hear it on 10 December 2024. Mr Lynch and his friend provided oral evidence and were cross examined by UKAD. 'In a decision issued on 16 January 2025, the NADP accepted the account put forward by Mr Lynch and concluded that Mr Lynch had established the source of ibutamoren and had not acted with intent, as defined by the Anti-Doping Rules. 'Assessing Mr Lynch's fault in committing the ADRVs (anti-doping rule violations), the NADP imposed a sixteen-month period of Ineligibility. 'Accounting for the period of time Mr Lynch spent provisionally suspended, his period of Ineligibility is deemed to have commenced on 2 February 2024 and will expire at 11:59pm on 1 June 2025.'
